Pyridoxine 50 mg tabs, blister of 28

General Description
Pyridoxine 50 mg tablets, blister of 28

Technical specifications:
Pyridoxine (hydrochloride) 50 mg tablets, blister of 28 tablets,
complying with one of the pharmacopeias:
BP
Ph.Eur.
Ph.Int.
USP
The tablets should comply with one of the pharmacopeias:
Ph.Eur , BP, Ph. Int, USP general monograph for tablets and general notices

Guidelines for use (labelling information):
It is used to treat low level of Vitamin B6 in the body and in the treatment of a condition called idiopathic sideroblastic anaemia where the red cells in the blood do not form properly.
Pyridoxine is recommended in HIV patients on isoniazid as it is benign intervention which prevents peripheral neuropathy and other isoniazid toxicities.
The dosing of pyridoxine when administered with isoniazid preventive therapy for HIV-infected individuals is 25-50mg daily:

Reference:
For general information on uses, contra-indications, precautions, dose, and adverse effects of this product, please refer to the WHO Model Formulary:
http://www.who.int/selection_medicines/list/WMF2008.pdf


Shelf life:
24 months at ICH zone II (25 +/- 2 C, 60% +/-5% RH)

Packaging and Labeling:
Tablets packed in blister of PVC/Alu or Alu/Alu 100, packed in a tightly closed, protected from light and moisture.